SELLAS closes $18.5M offering; reprices 3.4M warrants to $3.62

SELLAS Life Sciences Group, Inc.

Closed underwritten offering of 7,220,217 shares and warrants for net proceeds of ~$18.5M.
Amended 3,438,851 warrants issued April 2022, reducing exercise price from $5.40 to $3.62.
New exercise price equals average closing price over five trading days before offering pricing.
Offering and warrant amendments executed on February 28, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.